Fin Trust Capital Advisors, LLC Merck & Co., Inc. Transaction History

Fin Trust Capital Advisors, LLC

$577 Million
Q3 2024

A detailed history of Fin Trust Capital Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 6,490 shares of MRK stock, worth $643,613. This represents 0.13% of its overall portfolio holdings.

Number of Shares

6,490

Previous 7,492 13.37%

Holding current value

$643,613

Previous $927,000 20.5%

% of portfolio

0.13%

Previous 0.18%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$111.15 - $128.97 $111,372 - $129,227	-1,002 Reduced 13.37%	6,490 $737,000
Q2 2024 Jul 24, 2024	SELL	$123.8 - $132.96 $274,836 - $295,171	-2,220 Reduced 22.86%	7,492 $927,000
Q1 2024 May 02, 2024	BUY	$113.24 - $131.95 $115,391 - $134,457	1,019 Added 11.72%	9,712 $1.28 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $42,977 - $46,769	429 Added 5.19%	8,693 $947,000
Q3 2023 Oct 24, 2023	SELL	$102.95 - $114.33 $329,542 - $365,970	-3,201 Reduced 27.92%	8,264 $850,000
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $120,579 - $154,599	1,379 Added 13.67%	11,465 $1.27 Million
Q3 2022 Oct 20, 2022	BUY	$84.53 - $94.96 $334,231 - $375,471	3,954 Added 64.48%	10,086 $924,000
Q2 2022 Jul 26, 2022	BUY	$83.49 - $94.64 $9,935 - $11,262	119 Added 1.98%	6,132 $553,000
Q1 2022 May 03, 2022	BUY	$73.51 - $82.4 $123,496 - $138,432	1,680 Added 38.77%	6,013 $492,000
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $4,770 - $5,975	-66 Reduced 1.5%	4,333 $332,000
Q3 2021 Nov 16, 2021	SELL	$71.68 - $78.83 $13,690 - $15,056	-191 Reduced 4.16%	4,399 $330,000
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $2,272 - $2,676	-33 Reduced 0.71%	4,590 $354,000
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $50,023 - $55,516	-697 Reduced 13.1%	4,623 $378,000
Q3 2020 Nov 10, 2020	BUY	$73.18 - $82.95 $114,014 - $129,236	1,558 Added 41.41%	5,320 $441,000
Q2 2020 Sep 11, 2020	BUY	$70.42 - $80.13 $264,920 - $301,449	3,762 New	3,762 $291,000
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $287,243 - $326,850	-4,079 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $180,892 - $250,726	-2,855 Reduced 41.17%	4,079 $314,000
Q4 2019 Jan 23, 2020	BUY	$77.58 - $87.54 $152,134 - $171,665	1,961 Added 39.43%	6,934 $631,000
Q3 2019 Oct 29, 2019	BUY	$76.08 - $82.93 $76 - $82	1 Added 0.02%	4,973 $419,000
Q2 2019 Aug 01, 2019	SELL	$69.84 - $81.59 $24,723 - $28,882	-354 Reduced 6.65%	4,972 $417,000
Q1 2019 May 09, 2019	BUY	$69.58 - $79.36 $16,142 - $18,411	232 Added 4.55%	5,326 $443,000
Q4 2018 Feb 11, 2019	BUY	$65.24 - $75.71 $332,332 - $385,666	5,094 New	5,094 $389,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.

Account

Fin Trust Capital Advisors, LLC Merck & Co., Inc. Transaction History